Pharmasset

Biotech Stock Mailbag: Hep C Stock Winners
TheStreet.com
Fri, 04/8/11 - 10:56 am
hepatitis C
Pharmasset
Merck
Optimer
Vertex Pharmaceuticals
Gilead Sciences
JNJ
InterMune
Bristol-Myers Squibb
Biotech Busts And Breakthroughs For March
Forbes
Mon, 04/4/11 - 10:58 pm
Pharmasset
KV Pharmaceutical
Ista
Pain Therapeutics
Cytori
Biotech Stock Mailbag: Avanir Pharma
TheStreet.com
Fri, 04/1/11 - 10:08 am
Avanir
Alexza
Somaxon
Pharmasset
Radient Pharmaceuticals
RXi Pharmaceuticals
Idenix: Not Worth the Wait
Seeking Alpha
Thu, 03/17/11 - 11:01 am
Indenix
hepatitis C
Pharmasset
HCV
Who Will Win the Hepatitis C Market?
Seeking Alpha
Mon, 03/14/11 - 10:44 am
hepatitis C
Gilead Sciences
Merck
Bristol-Myers Squibb
Novartis
Pfizer
Vertex Pharmaceuticals
Pharmasset
Pharmasset: The Real Numbers Behind the Hype
Seeking Alpha
Fri, 03/11/11 - 11:44 am
Pharmasset
hepatitis C
Vertex drops on competitive fears
Bizjournals.com
Wed, 03/9/11 - 07:46 am
Vertex Pharmaceuticals
Pharmasset
hepatitis C
Telaprevir
Pharmasset 1Q loss widens on costs
Yahoo/AP
Tue, 02/8/11 - 09:25 am
earnings
Pharmasset
Bristol-Myers, Pharmasset plan hepatitis C study
Yahoo/AP
Mon, 01/10/11 - 12:23 pm
hepatitis C
Pharmasset
Bristol-Myers Squibb
Biotech Stock Mailbag: Best Stocks to Watch in '11
TheStreet.com
Fri, 01/7/11 - 07:21 am
Oncothyreon
Xoma
Amarin
Opexa
Human Genome
Seattle Genetics
Vertex Pharmaceuticals
Merck
Dendreon
Biogen Idec
Amgen
Pharmasset
Inhibitex: A Biotech Gem in the Enormous Hepatitis C Market
Seeking Alpha
Tue, 11/30/10 - 07:59 am
Inhibitex
hepatitis C
Pharmasset
Vertex Pharmaceuticals
Pharmasset Makes Remarkable Recovery on Hepatitis C Franchise
Seeking Alpha
Sun, 11/7/10 - 11:32 am
Pharmasset
hepatitis C
nucleoside polymerase inhibitor
RG7128
Roche
Biotech Calendar: Key Dates for November
TheStreet.com
Fri, 10/29/10 - 12:11 pm
biotech
Merck
Gilead Sciences
Indenix
Pharmasset
Bristol-Myers Squibb
Dendreon
Cadence Pharmaceuticals
Vical
MELA Sciences
Human Genome Sciences
Amgen
Time For Gilead To Open Its Wallet
Investopedia
Tue, 07/6/10 - 09:06 am
Gilead Sciences
Alexion
Human Genome Sciences
Seattle Genetics
Genzyme
Incyte
Targacept
M&A
Pharmasset
Pharmasset shares rise on positive study results for potential hepatitis C drug
Yahoo/AP
Thu, 06/10/10 - 09:45 am
Pharmasset
hepatitis C
Pharmasset publicly offers $92.8 million in stock
Yahoo/AP
Fri, 05/14/10 - 09:52 am
Pharmasset
stock offering
Biotech Calendar: Key Dates for April
TheStreet.com
Mon, 04/5/10 - 09:53 am
Forest Labs
Celgene
Genzyme
Lexicon Pharmaceuticals
Cell Therapeutics
Acadia
Acorda Therapeutics
Vertex Pharmaceuticals
Indenix
Pozen
Acura Pharmaceuticals
OSI Pharmaceuticals
Cyclacel
Peregrine Pharmaceuticals
Anadys
Pharmasset
Dendreon
What Investors Think About Pharmasset
Motley Fool
Thu, 02/11/10 - 12:17 pm
Pharmasset
On the Radar: November's biotech stocks to watch
Fierce Biotech
Wed, 11/18/09 - 12:19 pm
biotech
Cadence Pharmaceuticals
Micromet
Momenta
Pharmasset
Protalix BioTherapeutics
Biotech Calendar: Key Dates for November
TheStreet.com
Mon, 11/2/09 - 08:52 am
XenoPort
Vertex Pharmaceuticals
Schering Plough
Pharmasset
Merck
InterMune
Cephalon
Cadence Pharmaceuticals
biotech

Pages